Saltar al contenido
Merck

MHS1

Sigma-Aldrich

Mayer′s Hematoxylin Solution

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Número MDL:
Código UNSPSC:
41116124
ID de la sustancia en PubChem:
NACRES:
NA.47

formulario

solution

Nivel de calidad

caducidad

Expiry date on the label.

DIV

for in vitro diagnostic use

concentración

1 g/L

pH

2.4 (25 °C)

aplicaciones

hematology
histology

temp. de almacenamiento

room temp

cadena SMILES

Oc1cc2C[C@@]3(O)COc4c(O)c(O)ccc4[C@H]3c2cc1O

InChI

1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2/t13-,16+/m0/s1

Clave InChI

WZUVPPKBWHMQCE-XJKSGUPXSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Descripción general

Used as a counterstain for procedures such as immunohistochemistry or laser microdissection.

Aplicación

General purpose nuclear stain, progressive type. Used with hematoxylin and eosin staining.

Otras notas

1 g/L certified hematoxylin

Código de clase de almacenamiento

12 - Non Combustible Liquids

Clase de riesgo para el agua (WGK)

WGK 2

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Michael Taylor Hensley et al.
Journal of cellular and molecular medicine, 21(8), 1503-1512 (2017-03-16)
Cardiosphere-derived cells (CDCs) have been shown to reduce scar size and increase viable myocardium in human patients with mild/moderate myocardial infarction. Studies in rodent models suggest that CDC therapy may confer therapeutic benefits in patients with non-ischaemic dilated cardiomyopathy (DCM).
Shih-Jie Jhuo et al.
International journal of molecular sciences, 22(11) (2021-07-03)
Empagliflozin (EMPA) is a sodium-glucose transporter 2 (SGLT2) inhibitor that functions as a new-generation glucose-lowering agent and has been proven to be beneficial for patients with cardiovascular diseases. However, the possible benefits and mechanisms of its antiarrhythmic effects in cardiac
Gretchen M Alicea et al.
Cancer discovery, 10(9), 1282-1295 (2020-06-06)
Older patients with melanoma (>50 years old) have poorer prognoses and response rates to targeted therapy compared with young patients (<50 years old), which can be driven, in part, by the aged microenvironment. Here, we show that aged dermal fibroblasts
Darby A Houck et al.
Orthopaedic journal of sports medicine, 7(12), 2325967119888173-2325967119888173 (2020-01-07)
Arthroscopic capsular release (ACR) for the treatment of adhesive capsulitis of the shoulder can be performed in either the beach-chair (BC) or lateral decubitus (LD) position. To determine the clinical outcomes and recurrence rates after ACR in the BC versus
Amanpreet Kaur et al.
Cancer discovery, 9(1), 64-81 (2018-10-04)
Physical changes in skin are among the most visible signs of aging. We found that young dermal fibroblasts secrete high levels of extracellular matrix (ECM) constituents, including proteoglycans, glycoproteins, and cartilage-linking proteins. The most abundantly secreted was HAPLN1, a hyaluronic

Protocolos

Use this protocol to for the entire immunohistochemistry (IHC) procedure through staining and visualization of specific antigens in paraffin-embedded tissue sections.

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico